Methotrexate-based Chemo-immunotherapy Followed by Maintenance Therapy for Patients > 65 Years With Central Nervous System (CNS)-Lymphoma

NCT00989352 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Primary Non Hodgkin Lymphoma of the Central Nervous System

Interventions

DRUG: Methotrexate
DRUG: Lomustine
DRUG: Procarbazine
DRUG: Rituximab

Sponsor

University Hospital Freiburg

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]